With close to one million downloads, Shotsy is the most popular GLP-1 tracking app on the market, and now meets patients at ...

A U.S. court has certified a nationwide class of third party payors in racketeering litigation tied to the diabetes drug Actos. The class includes U.S. insurers and other payors that reimbursed for ...

Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

As FiercePharma explains, the company is attempting to rebrand itself in the wake of a Justice Department investigation, a class-action lawsuit, and a failed attempt at treating Alzheimer’s. Plus: The ...

Yet American health care has in the past proved resistant to treatment from disrupters. In 2008 Google, a search colossus, ...

Wolfe said the oral GLP-1 therapy could broaden the obesity treatment market because it combines strong weight-loss results ...

For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...

Aditya Dhar's Dhurandhar, one of the biggest hits in recent times, also employs an unusual, eight-chapter narrative to tell the story of spies ...

STOCKHOLM, SE / ACCESS Newswire / March 12, 2026 / iZafe Group (STO:IZAFE-B) - An Extraordinary General Meeting was held in iZafe Group AB, reg. no. 556762-3391 (the "Company"), on 12 March 2026 at th ...

A patient audit of more than 1,000 lupus nephritis charts highlights growing experience with biologics and calcineurin ...

Belpointe PREP LLC operates as a real estate company. It focuses on identifying, acquiring, developing or redeveloping and managing commercial real estate located within qualified opportunity zones.

Plenty of new dramas to enjoy this week, from the return of The Capture and Ellis to a new adaptation of A Woman of Substance – plus Claudia Winkleman hosts her own chatshow in Graham Norton’s slot.